Genmab — Juni 2020

[JohnW]

Tak for link.

[Bulder]

Studiet ovenfor er også Isa+RVd. Her er dara forlængst i fase 3 med Cepheus-studiet, og i forvejen godkendt med Rd i non-asct-setting.

[GeorgeBest]

Genmab to Participate in a Virtual Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference https://ir.genmab.com/news-releases/news-release-details/genmab-participate-virtual-fireside-chat-goldman-sachs-41st

[GeorgeBest]

kl. 21 i dag

[GeorgeBest]

korrektion kl 21 den 11. juni

[GeorgeBest]

hhmm Antony Pagano i stedet for JvdW

[E_L]

this SY-1425 combi for MDS seems fully recruited, didn't thinke we would hear from that again, primary completion date this month, maybe we can get some data at some point https://clinicaltrials.gov/ct2/history/NCT02807558?A=14&B=15&C=merged#StudyPageTop

[BioShare]

Jan har ikke tid...kan bare ikke den dag....han har nogle papirer som skal underskrives.....

[Vitus]

Hvordan skal det lige forståes ?

[gdn55]

Jo, eller barsel

[E_L]

@kkjoel so you were right; it was 15

[E_L]

Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma

Company Announcement Subcutaneous fixed-dosed formulation of DARZALEX® (daratumumab) approved in Europe for the treatment of adult patients with multiple...

GlobeNewswire News Room (www.globenewswire.com)

[kkjoel]

Yup, it sure sounded like that.. men 15 eller 50.. tomatos-tomaaatos

[E_L]

European Marketing Authorization for the Subcutaneous Formulation of DARZALEX

[E_L]

lol

[kkjoel]

:-9

[kkjoel]

Der kom den sgu - den europæiske dara sc!

[E_L]

that is pretty fast , no? just over 1 month to confirm CHMP opinio

[E_L]

n

[Bulder]

Stod der noget godt i den Børsen-artikel?